September 21, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
Teleconference Meeting
NIH – Building 29B/Conference Room C
September 21, 2010
DRAFT AGENDA

Open Session

Presentation of Laboratory of Respiratory & Special Pathogens, Division of Bacterial, Parasitic, & Allergenic Products; Laboratory of Hepatitis Viruses, and Laboratory of Vector Borne Virus Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research

2:00 p.m.	Overview of Research/Site Visit Process, Center Biologics Evaluation and Research (CBER)	Carolyn Wilson, Ph.D., FDA
2:10	Overview of Office of Vaccines Research and Review (OVRR), CBER	Konstantin Chumakov, Ph.D., FDA
2:20	Overview of Division of Bacterial, Parasitic & Allergenic Products (DBPAP), OVRR	Jay Slater, M.D., FDA
2:30	Overview of Laboratory of Respiratory & Special Pathogens	Drusilla Burns, Ph.D., FDA
2:55	Q&A
3:00	Overview of Division of Viral Products (DVP), OVRR	Jerry Weir, Ph.D., FDA
3:10	Overview Laboratory of Hepatitis Viruses	Stephen Feinstone, M.D., FDA
3:35	Q&A
3:40	Overview of Laboratory of Vector Borne Virus Diseases	Lewis Markoff, M.D., FDA
4:05	Q&A
4:10	Open Public Hearing (if no speakers, will move directly to closed session)
5:10	Closed Session
6:00	Adjourn Meeting